The University of Texas MD Anderson Cancer Center
Department of Hematopathology

Dr. Jie Xu has received her MD from Hubei Medical University and her PhD from University of Alabama at Birmingham. She is currently an assistant professor in the Department of Hematopathology at the University of Texas MD Anderson Cancer Center. She is board certified by the American Board of Pathology in Anatomic Pathology, Clinical Pathology, and Hematology. In addition to clinical responsibilities on the diagnosis of Leukemia and Lymphoma, Dr. Xu has been actively participating in multiple research projects in lymphoma and leukemia, which has led to 60 research papers. She serves as members of editorial boards for 4 journals and ad hoc reviewers for 6 journals. Her major research interests include molecular genetic aberrations, diagnosis, and prognosis of lymphoma and leukemia, and minimal residual disease monitoring of hematopoietic neoplasms by flow cytometry.

RESEARCH INTERESTS

Molecular genetic aberrations in lymphoma and leukemia.

Clinicopathologic features and prognostic risk factors of lymphoma and leukemia.

Minimal residual disease monitoring of hematopoietic neoplasms by flow cytometry.

PubMed

Education & Training

M.D. - Hubei Medical University - 1993
Ph.D. - University of Alabama at Birmingham, 2005